Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Documenti analoghi

• Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.
  di: Bernard, S., et al.
  Pubblicazione: (1991)
• Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity
  di: Fischel, J L, et al.
  Pubblicazione: (2002)
• Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
  di: Fischel, J-L, et al.
  Pubblicazione: (2001)
• Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.
  di: Thyss, A., et al.
  Pubblicazione: (1986)
• Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil
  di: Magné, N, et al.
  Pubblicazione: (2003)